DRTS

Quote

Short

News

Articles

Message Board

Buy Recommendation Issued On DRTS By H.C. Wainwright

September 03, 2025 08:15:04 am

Source: KlickAnalytics

2025-09-03 08:15:04 ET

H.C. Wainwright analyst issues BUY recommendation for DRTS on September 3, 2025 10:51AM ET.

The previous analyst recommendation was Buy.

DRTS was trading at $3.48 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 4 - Buy recommendations .

Historical Analyst Recommendations

Latest 10 recommendations

Full story available on KlickAnalytics.com

Alpha Tau Medical Ltd.

NASDAQ: DRTS

DRTS Trading

0.42% G/L:

$7.13 Last:

69,256 Volume:

$6.97 Open:

mwn-alerts Ad 300

DRTS Latest News

March 09, 2026 04:02:00 pm

Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update

February 24, 2026 11:03:49 am

DRTS Price Target Alert: $12.00. Issued by H.C. Wainwright

February 24, 2026 09:00:00 am

Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer

January 29, 2026 09:00:00 am

Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead

DRTS Stock Data

Market Cap $624,275,171

Float 56,235,657

Insiders Ownership N/A

Institutions 20

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.alphatau.com

Country IL

City Jerusalem

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App